We value our peers within the biotech space and this is how we show it. Our monthly newsletter, The Trebla Times, is our way of relaying layoffs, offers, active searches and so much more to those who are interested.
The three most recent editions of the Trebla Talent newsletter.
M&A Breaks Records, Big Pharma Leads Layoffs
2026 hit 57 acquisitions in July, surpassing all of last year, with argenx and Vertex closing two of the biggest deals. Layoffs shifted from small biotech to large pharma, with Genentech, Novartis, and Amgen all announcing cuts. Natalia and her now wife Becca tied the knot at San Francisco City Hall!
Read Edition June 2026Historic M&A Run, Speed & Strategy Separate Top Hirers
2026 is on pace to be the strongest year for biotech dealmaking since 2019, with AbbVie and GSK closing two blockbuster acquisitions totaling over $21B. June saw the highest layoff count in recent months, with 8 announcements across the industry. We also broke down four real executive compensation packages to help you benchmark your searches.
Read Edition May 2026Strong Momentum, Shrinking Candidate Pool
Layoffs stayed quiet and the pool of available talent is shrinking fast, meaning companies must now compete harder to win top candidates. Three major M&A deals closed including Angelini ($4.1B), Bayer ($2.45B), and UCB ($2.2B). AVEO Oncology joined the Trebla Tribe!
Read Edition